The results show that the polycation/siRNA/PFOB nanoemulsions are capable of efficiently silencing the expression of STAT3 and inhibiting chemokine receptor CXCR4—two validated targets in pulmonary fibrosis. Here, CXCR4 is linked to pulmonary fibrosis.